How the New Classification Affects Cosmetic Packaging
Regulatory changes in the cosmetics industry require constant attention from manufacturers and distributors. The recent borderline update regarding vial and ampoule classification introduces new guidelines that can significantly impact compliance in the EU and UK markets. As these packaging formats become more popular in cosmetics, regulatory bodies are paying closer attention to how they are marketed and whether they might be mistakenly perceived as pharmaceutical products.
Understanding these updates is crucial to avoiding unnecessary reclassification, which could lead to additional regulatory hurdles, increased compliance costs, and even restrictions on sales. Brands using vials and ampoules must now carefully review their packaging, marketing claims, and overall product positioning to ensure compliance with the latest guidelines.
What’s Changing with Vials and Ampoules in Cosmetics?
Vials and ampoules have long been associated with the pharmaceutical industry due to their ability to preserve active ingredients and provide precise dosing. However, their growing use in cosmetics has led regulatory bodies to establish clearer distinctions between cosmetic and medicinal packaging.
A product packaged in a vial or ampoule that suggests therapeutic effects or resembles pharmaceutical packaging too closely may no longer be classified as a cosmetic product. The way the packaging is presented, along with the wording used in marketing materials, plays a crucial role in determining whether the product remains under cosmetic regulations or requires additional approvals.
For instance, phrases such as “clinically proven,” “medical-grade results,” or “dermatologically tested for treatment” can create the impression that the product is medicinal rather than cosmetic. Additionally, the more sterile and pharmaceutical-like the packaging appears, the higher the likelihood of regulatory scrutiny.
What Does This Mean for Cosmetic Brands?
For brands using vials and ampoules, these regulatory changes mean that packaging design and marketing strategies must be carefully evaluated. A product’s intended use, appearance, and marketing claims must clearly communicate its cosmetic nature without implying medical benefits.
If a product is deemed to resemble pharmaceutical packaging or suggest medicinal effects, it may face reclassification, additional regulatory requirements, or even sales restrictions. This can have significant consequences for a brand’s ability to market and distribute its products across the EU and UK.
To remain compliant, brands should review their packaging, advertising materials, and product claims to ensure they do not create misleading associations with pharmaceuticals. Conducting a regulatory compliance check can help identify potential risks and necessary adjustments before they lead to regulatory intervention.
How to Ensure Compliance with the New Regulations
With these new updates, staying compliant requires a proactive approach. Brands should assess whether their product packaging and marketing of vials and ampoules materials align with regulatory expectations to avoid potential reclassification. It’s important to ensure that cosmetic vials and ampoules are presented as beauty products, rather than pharmaceutical treatments.
If you’re uncertain whether your products meet compliance requirements, conducting a regulatory assessment can help mitigate risks. Working with regulatory experts can provide clarity on how to position your products correctly while maintaining compliance with EU and UK regulations.
Need guidance on compliance?
Our team at Burstein EU specializes in cosmetic regulations, product classification, and compliance support. Contact us today for expert assistance.
Get a free compliance consultation!
Taking Action to Stay Compliant
The latest borderline update on vials and ampoules in cosmetics highlights the importance of clear product positioning and regulatory awareness. As packaging trends evolve, brands must adapt to ensure their products remain compliant with industry regulations. By carefully reviewing packaging design and marketing claims, businesses can continue to sell their products without regulatory complications.
Here are official sources where you can find more information on the classification of cosmetic products packaged in vials and ampoules:
The European Commission has published an updated Borderline Manual, which includes a new section (3.3.34) on vial and ampoule packaging. This section provides guidelines for determining whether these products meet the criteria for classification as cosmetic products under the EU Cosmetics Regulation (Regulation (EC) No 1223/2009).
The European Commission provides guidance on borderline cases, where it is unclear whether a product falls under cosmetic legislation or other sectoral legislation. These guidelines are essential for understanding how cosmetic vial and ampoule products may be classified.
Tea Tree Oil CMR Classification in GB vs EU Explained
Did you know that the changing landscape of cosmetic regulations...
Read More
Sunscreen Revolution US What You Need to Know Now
Did you know that the United States has been working...
Read More
EU deforestation regulation delay faces second review
Is the EU backtracking its climate and sustainability objectives with...
Read More
ECHA Seeks Input on Octocrylene Environmental Risks
Did you know a common UV filter in your sunscreen...
Read More